OrbiMed’s BrightSpring Health Services BTSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-497,800
Closed -$21.2M 151
2026
Q1
$21.2M Buy
497,800
+9,300
+2% +$375K 0.42% 55
2025
Q4
$18.3M Buy
488,500
+224,700
+85% +$7.54M 0.37% 63
2025
Q3
$7.8M Buy
+263,800
New +$6.13M 0.18% 79

Other funds holding BTSG

OrbiMed's BTSG Position: Q2 2026 in Review

OrbiMed sold out of BrightSpring Health Services (BTSG) in Q2 2026, closing a stake of 497,800 shares — an estimated $21.2M sold.

OrbiMed first reported a position in BTSG in Q3 2025 and held it in 3 quarters. The position peaked at $21.2M in Q1 2026. 423 funds tracked by Wall St. Rank hold BTSG as of Q2 2026.

  • OrbiMed reported no remaining BrightSpring Health Services position as of Q2 2026 after selling out during the quarter.
  • OrbiMed sold 497,800 BrightSpring Health Services shares in Q2 2026, an estimated $21.2M.
  • OrbiMed first reported a position in BrightSpring Health Services in Q3 2025 and held it in 3 quarters.
  • OrbiMed's BrightSpring Health Services position peaked at $21.2M in Q1 2026.
  • 423 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q2 2026.

Based on OrbiMed's 13F filing for Q2 2026, filed 14 Aug 2026.